We are live on ! Find out more
WFI

West Family Investments Portfolio holdings

AUM $345M
1-Year Est. Return 46.29%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+46.29%
3 Year Est. Return
+116.17%
5 Year Est. Return
+113.18%
10 Year Est. Return
+254.99%
AUM
$266M
AUM Growth
-$21.4M
Cap. Flow
-$31.2M
Cap. Flow %
-11.74%
Top 10 Hldgs %
39.85%
Holding
313
New
29
Increased
54
Reduced
113
Closed
41

Top Buys

Rank Stock Value
1
SCHP icon
Schwab US TIPS ETF
SCHP
+$429K
2
AAPL icon
Apple
AAPL
+$381K
3
PFE icon
Pfizer
PFE
+$370K
4
KMB icon
Kimberly-Clark
KMB
+$317K
5
KDP icon
Keurig Dr Pepper
KDP
+$296K

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.68M
2
LLY icon
Eli Lilly
LLY
+$2.54M
3
IAU icon
iShares Gold Trust
IAU
+$2.37M
4
META icon
Meta Platforms (Facebook)
META
+$1.62M
5
CRSP icon
CRISPR Therapeutics
CRSP
+$1.4M

Sector Composition

Rank Sector Weight
1 Technology 18.44%
2 Financials 10.92%
3 Healthcare 9.18%
4 Energy 7.32%
5 Communication Services 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
26
Broadcom
AVGO
$1.98T
$1.64M 0.62%
9,801
-3,626
-27% -$767K
WM icon
27
Waste Management
WM
$90.5B
$1.63M 0.61%
7,038
– –
CVS icon
28
CVS Health
CVS
$121B
$1.62M 0.61%
23,924
+1,212
+5% +$72.5K
MA icon
29
Mastercard
MA
$490B
$1.62M 0.61%
2,949
– –
XOM icon
30
ExxonMobil
XOM
$657B
$1.6M 0.6%
13,465
-202
-1% -$22.3K
MCD icon
31
McDonald's
MCD
$195B
$1.53M 0.57%
4,886
+10
+0.2% +$2.99K
MRK icon
32
Merck
MRK
$328B
$1.5M 0.56%
16,685
+439
+3% +$41K
IBN icon
33
ICICI Bank
IBN
$107B
$1.49M 0.56%
47,402
-6,400
-12% -$186K
ABBV icon
34
AbbVie
ABBV
$440B
$1.49M 0.56%
7,098
+3
+0% +$583
CSCO icon
35
Cisco
CSCO
$488B
$1.47M 0.55%
23,796
– –
TMUS icon
36
T-Mobile US
TMUS
$190B
$1.43M 0.54%
5,369
-537
-9% -$132K
SHEL icon
37
Shell
SHEL
$249B
$1.42M 0.53%
19,373
-425
-2% -$28.6K
KO icon
38
Coca-Cola
KO
$373B
$1.32M 0.5%
18,495
+2,741
+17% +$183K
VZ icon
39
Verizon
VZ
$195B
$1.3M 0.49%
28,552
+2,404
+9% +$100K
KR icon
40
Kroger
KR
$34.3B
$1.26M 0.47%
18,564
– –
LLY icon
41
Eli Lilly
LLY
$1.09T
$1.24M 0.47%
1,498
-3,053
-67% -$2.54M
PEP icon
42
PepsiCo
PEP
$189B
$1.23M 0.46%
8,196
-1,136
-12% -$169K
MRSH
43
Marsh
MRSH
$90.1B
$1.19M 0.45%
4,878
– –
WIT icon
44
Wipro
WIT
$19.3B
$1.19M 0.45%
388,195
-12,051
-3% -$41.1K
NVS icon
45
Novartis
NVS
$290B
$1.12M 0.42%
10,009
– –
HDB icon
46
HDFC Bank
HDB
$119B
$1.1M 0.42%
33,178
-4,240
-11% -$129K
NVO
47
Novo Nordisk
NVO
$203B
$1.1M 0.42%
15,871
-4,502
-22% -$372K
INFY icon
48
Infosys
INFY
$49.7B
$1.08M 0.41%
59,338
+6,534
+12% +$136K
GILD icon
49
Gilead Sciences
GILD
$168B
$1.08M 0.41%
9,639
– –
T icon
50
AT&T
T
$166B
$1.07M 0.4%
37,961
– –
1
2
3 4 5

Similar funds

PFMOSF
Philadelphia Financial Management of San Francisco San Francisco, California $346M AUM 30.02% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
GLCM
Greenlea Lane Capital Management Weston, Connecticut $344M AUM 14.33% 1-Year Est. Return
VW
Vance Wealth Santa Clarita, California $346M AUM 19.74% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $344M AUM 23.98% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $346M AUM 25.49% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $344M AUM 44.86% 1-Year Est. Return

West Family Investments's Q1 2025 Portfolio in Review

As of Q1 2025, West Family Investments held 313 positions worth $266M, down 7.5% from $287M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

West Family Investments withdrew a net $31.2M in Q1 2025, closing 41 positions and reducing 113 holdings. Its most notable exit was CRISPR Therapeutics, an estimated $1.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, West Family Investments opened a new position in Pfizer worth $359K.

  • West Family Investments's largest Q1 2025 buy was Pfizer: 14,151 shares worth $359K.
  • West Family Investments added most to Schwab US TIPS ETF in Q1 2025, an estimated $429K increase.
  • West Family Investments's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.68M.
  • West Family Investments fully exited CRISPR Therapeutics in Q1 2025, selling an estimated $1.4M.
  • West Family Investments's ten largest holdings make up 40% of its $266M portfolio in Q1 2025.
  • West Family Investments opened 29 new positions and closed 41 in Q1 2025.
  • West Family Investments's portfolio value fell 7.5% quarter-over-quarter to $266M.

Based on West Family Investments's 13F filing for Q1 2025, filed 2 May 2025.